CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 11:50 AM GMTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
Health Bulletin 16/December/2022 Dr. Nandita Mohan16 Dec 2022 11:10 AM GMTHere are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical...
CDSCO opines J&J to submit details of Anticancer Drug Teclistamab approval in EU, US Dr. Divya Colin15 Dec 2022 12:30 PM GMTNew Delhi: In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and...
Janssen Pharma seeks USFDA nod for Teclistamab to treat multiple myeloma Ruchika Sharma30 Dec 2021 5:45 AM GMTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S....
Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma Hina Zahid31 Dec 2020 12:00 PM GMTPHILADELPHIA - A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients...
